Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
Health & Fitness
Technology
About Us
Contact Us
Copyright
© 2024 PodJoint
Loading...
0:00 / 0:00
Podjoint Logo
US
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts221/v4/73/33/47/73334720-ead2-282c-f69a-79c154f89742/mza_14915466023666217570.jpg/600x600bb.jpg
The Investor Relations Podcast
Joshua Wilson
165 episodes
2 months ago
In this episode of The Investor Relations Podcast, Michael Loftus, Biotech Growth Architect and Family Office Strategist, shares his perspective on what makes investor relations effective in the fast-moving world of life sciences. Drawing from his experience at the intersection of biotech investing, clinical trials, and family office strategy, Michael explains how companies can strengthen relationships with investors and avoid common pitfalls. The conversation explores why biotech companies m...
Show more...
Investing
Education,
Business,
Careers,
How To
RSS
All content for The Investor Relations Podcast is the property of Joshua Wilson and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The Investor Relations Podcast, Michael Loftus, Biotech Growth Architect and Family Office Strategist, shares his perspective on what makes investor relations effective in the fast-moving world of life sciences. Drawing from his experience at the intersection of biotech investing, clinical trials, and family office strategy, Michael explains how companies can strengthen relationships with investors and avoid common pitfalls. The conversation explores why biotech companies m...
Show more...
Investing
Education,
Business,
Careers,
How To
Episodes (20/165)
The Investor Relations Podcast
Biotech & Life Sciences Investor Relations
In this episode of The Investor Relations Podcast, Michael Loftus, Biotech Growth Architect and Family Office Strategist, shares his perspective on what makes investor relations effective in the fast-moving world of life sciences. Drawing from his experience at the intersection of biotech investing, clinical trials, and family office strategy, Michael explains how companies can strengthen relationships with investors and avoid common pitfalls. The conversation explores why biotech companies m...
Show more...
2 months ago
1 minute

The Investor Relations Podcast
Building Lifelong Investor Relationships with Family Offices
What’s the secret to building long-term capital partnerships with family offices? In this episode of The Investor Relations Podcast, host Joshua Wilson is joined by Dr. Thomas J Powell, Founder of The Founder’s Office™, to explore the mindset and practices that foster lifelong investor trust. Dr. Powell explains why the first investment is just the beginning of the relationship—and how transparent communication during both growth and turbulence separates short-term managers from lasting leade...
Show more...
2 months ago

The Investor Relations Podcast
What Licenses Does a Family Office CIO Need?
In this episode of The Investor Relations Podcast, host Joshua Bruce Wilson asks Brian Adams what kind of licenses — if any — a Chief Investment Officer needs to operate within a family office. Brian explains that many family offices operate under the family office exemption, meaning they are not required to register as an RIA or broker-dealer. As a result, CIOs in these settings often do not carry securities licenses. Instead, families typically look for professionals with a tax or legal bac...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
What 30+ Years of Capital Raising Taught This Family Office Leader
In this episode of The Investor Relations Podcast, Joshua Bruce Wilson sits down with Dr. Thomas J. Powell, founder of The Founder’s Office™, to explore what it really takes to manage investor relationships across decades, deals, and global markets. With over $3.2 billion in capital structured throughout his career, Dr. Powell shares his perspective on the evolving role of investor relations—not just as a transaction function, but as an essential discipline in strategic leadership. Tom walks ...
Show more...
3 months ago

The Investor Relations Podcast
Biotech Turnaround Strategies
Unlocking Success in Biotech: Turnaround Strategies with Allan Shaw 🔍 In the ever-evolving world of biotech and life sciences, sometimes doing less can mean achieving more. In my recent conversation with Allan Shaw, renowned as the "biotech turnaround guy," we delved into the art of focus and specialization. Allan shares how understanding and honing in on what you do best can lead to a remarkable turnaround for struggling companies. 💡 "You can't focus on everything. Sometimes it's about recog...
Show more...
3 months ago

The Investor Relations Podcast
Essential First Steps to Pursue a Role in Investor Relations
Building Relationships in Investor Relations: Key Advice for Aspiring Professionals This episode explores essential advice for those looking to enter the world of Investor Relations (IR) and work with publicly traded companies. Highlighting the dynamic and exciting nature of the role, the speaker emphasizes the importance of building relationships with investors and industry peers. The key takeaway is the value of connecting with experienced IR professionals and seeking mentorship, as t...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
What Aspiring CIOs Should Know About Family Office Careers
In this episode of The Investor Relations Podcast, Josh Wilson and Brian Adams explore what it takes to become a future Chief Investment Officer (CIO) in the world of family offices. Whether you're aiming for a single-family office, multi-family office, or institutional hybrid structure, the path to CIO is both competitive and nuanced. Brian explains that while institutional experience—such as investment banking or hedge fund training—can be foundational, it’s broad, cross-asset knowledge and...
Show more...
3 months ago
2 minutes

The Investor Relations Podcast
Earnings Calls: Insights and Importance
Understanding the Importance of Quarterly Earnings Calls In this insightful episode, we delve into the significance of earnings calls for businesses, particularly focusing on quarterly earnings calls for U.S. companies. We discuss the pivotal role these calls play in not only reporting past performance but also in addressing current challenges and future projections. With the ever-changing economic and geopolitical landscape, it's crucial for companies to communicate their strategies an...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
Tracking the Full Cycle of Early Stage Companies to IPO or M&A
Navigating the IPO & M&A Landscape: Why Tracking Matters 🌟 Why is it crucial to keep a close eye on early-stage companies as they journey towards IPO or M&A activities? Insights shared by industry Nick Gershenhorn reveal how staying informed about these strategic milestones can arm you with valuable information to benchmark against competitors. Discover the importance of being prepared before investor queries escalate and learn how critical events like S-1 filings unveil key finan...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
The 4-Point Investor Match Test For Capital Raising
Mastering Investor Qualification: Tips for Founders In this episode, we dive deep into the essential criteria for pre-qualifying investors. The discussion highlights four key aspects: geography, check size, investment stage, and industry verticals. By understanding these elements, founders can better identify suitable investors and improve their chances of successful funding. Tune in to gain valuable insights on using platforms like OpenVC to enhance your investor knowledge. Discl...
Show more...
3 months ago
3 minutes

The Investor Relations Podcast
Key Expectations for Board Members in a Biopharmaceutical IPO
Exciting insights on the essential expectations for board members at biopharmaceutical companies preparing for an IPO. 🎯 Join us as Josh Wilson and Allan Shaw discuss the importance of having independent board members with financial expertise, clinical experience, and commercial acumen. Discover how these key roles help drive milestones and monetize assets effectively. #Biopharma #IPO #BoardLeadership #Insights" Disclaimer: Joshua Wilson is a registered investment banking re...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
Why Are RIAs Attractive for Fund Managers Seeking Capital?
Discover why RIAs are becoming the go-to choice for fund managers seeking flexible capital! From understanding the entrepreneurial mindset to navigating substantial liquidity events, RIAs, private wealth managers, and family offices offer unique advantages in the investment landscape. Join Brian McKelvey as he delves into the benefits of targeting the RIA sector, exploring how this focus can enhance capital raising strategies and forge strong connections with like-minded professionals. Don't ...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
What is the Role of a Family Office CIO?
In this episode of The Investor Relations Podcast, Josh Wilson speaks with Brian Adams about the evolving investment strategy of single family offices—particularly the shifting role of the Chief Investment Officer (CIO). Brian outlines a growing trend: moving away from traditional active management and toward more direct, collaborative investment approaches. Family offices are increasingly building in-house investment capabilities focused on co-syndication, direct deal flow, and partnering wi...
Show more...
3 months ago

The Investor Relations Podcast
What Makes a Great Fortune 500 CEO?
Ever wondered what sets a great Fortune 500 CEO apart? 🌟 In a recent conversation with Jim Keyes, we delve into the essence of leadership at the top levels of major organizations. Jim's powerful advice? Forget the countless books on management—you must embrace learning continuously. As he puts it, "The only certainty in life is change, and change equals opportunity." Join us in exploring how top CEOs turn change into opportunity and thrive amidst uncertainty. Don't miss this insightful discus...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
How to Understand Investors’ Needs
Understanding Investor Needs: The Importance of Thoughtful Engagement In this episode, the discussion revolves around the crucial approach of understanding and addressing the specific needs and mandates of institutional investors. Rip shares insights on the importance of putting oneself in the investor's shoes, gathering detailed information about their background, team, company, mission, and portfolio. This thoughtful engagement strategy, including going to meetings with a blank pad an...
Show more...
3 months ago
2 minutes

The Investor Relations Podcast
13F Filings: Implications for Small and Large Companies
Understanding 13F Filings: Their Impact on Small and Large Companies Navigating the financial landscape can be daunting given the abundance of terminology and regulatory filings one must understand. One such critical form to grasp is the 13F filing. This article delves into what a 13F is and explores its relevance to both small and large public companies. What is a 13F Filing? In the realm of investor relations, a 13F filing is a report mandated by the Securities and Exchange Commission (SEC)...
Show more...
3 months ago
2 minutes

The Investor Relations Podcast
What Makes an Investment Attractive for Institutional Investors
Evaluating Investment Suitability for Institutional Investors This episode explores what makes an investment attractive to institutional investors. The primary focus is on the importance of aligning investments with the specific objectives and needs of different types of investors, including family offices, corporate pension plans, state college endowments, and insurance companies. Key considerations for determining an investment's attractiveness are discussed, emphasizing the suitabili...
Show more...
3 months ago

The Investor Relations Podcast
How Can IR Firms Efficiently Track Market Events?
Maximizing IR Teams' Efficiency with Listing Track's Market Monitoring Tools Explore how IR teams can enhance their market monitoring using tools from Listing Track. These solutions help IR professionals stay informed about industry events such as new IPOs, mergers, and sector-specific moves, all in one simplified platform, allowing them to better serve their clients and stay ahead of the competition. Disclaimer: Joshua Wilson is a registered investment banking representative and a licensed r...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
Balancing an IR Career and Family Life
Balancing Family Life and Professional Travel: Insights from an IR Professional In this episode, Ben discusses the challenges and strategies of balancing a demanding travel schedule with family life as an Investor Relations (IR) professional. He shares a valuable analogy comparing balance to riding a bike, emphasizing the importance of continuous movement to prevent imbalance. Ben provides practical advice on maximizing productivity while traveling and being fully present with his famil...
Show more...
3 months ago
1 minute

The Investor Relations Podcast
How Family Offices Are Shaping Investor Relations
In this episode of The Investor Relations Podcast, we sit down with Brian Adams, a partner at a boutique executive search firm serving single-family offices nationwide. Brian shares how his team helps family offices identify and hire top C-suite talent, including CEOs, CIOs, CFOs, and general counsel. His work spans across some of the most complex and discreet investment organizations in the country. Brian also discusses the growing interest from fund managers, sponsors, and capital raisers i...
Show more...
3 months ago

The Investor Relations Podcast
In this episode of The Investor Relations Podcast, Michael Loftus, Biotech Growth Architect and Family Office Strategist, shares his perspective on what makes investor relations effective in the fast-moving world of life sciences. Drawing from his experience at the intersection of biotech investing, clinical trials, and family office strategy, Michael explains how companies can strengthen relationships with investors and avoid common pitfalls. The conversation explores why biotech companies m...